Patent · US Active

IFNGR binding synthetic cytokines and methods of use

US12122839B2 · kind B2 · utility

0Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2021
Grant dateOct 22, 2024
Priority date—
Expiry dateAug 5, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are IFNGR binding molecules that bind to IFNGR1 and IFNGR2 and comprise an anti-IFNGR2 sdAb and an anti-IFNGR2 VHH antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.